Amsterdam Neuroscience
-
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Waterink, L., Masselink, L. A., van der Lee, S. J., Visser, L. N. C., Cleutjens, S., van der Schaar, J., van Harten, A. C., Scheltens, P., Sikkes, S. A. M., van der Flier, W. M. & Zwan, M. D., 1 Dec 2024, In: Alzheimer's Research & Therapy. 16, 1, p. 1 1.Research output: Contribution to journal › Article › Academic › peer-review
-
How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment
van Maurik, I. S., Bakker, E. D., van Unnik, A. A. J. M., Broulikova, H. M., Zwan, M. D., Berkhof, J., Bouwman, F. H., Bosmans, J. E., van der Flier, W. M. & van de Giessen, E., 1 Dec 2023, In: Alzheimer's Research and Therapy. 15, 1, p. 208 208.Research output: Contribution to journal › Article › Academic › peer-review
-
Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
Collij, L. E., Farrar, G., Zwan, M., Ossenkoppele, R., Barkhof, F., Rozemuller, A. J. M., Pijnenburg, Y. A. L., van der Flier, W. M. & Bouwman, F., Dec 2023, In: Alzheimer's Research and Therapy. 15, 1, 207.Research output: Contribution to journal › Article › Academic › peer-review
- All publications